Original Research

Regional tenders on biosimilars in Italy: potentially competitive?

Published in: Volume 2 / Year 2013 / Issue 3
Author(s): , , , ,
Page: 123-9

Author byline as per print journal: Alessandro Curto, MSSc, Katelijne Van de Vooren, MSc, Roberta Lo Muto, MSc, Silvy Duranti, MBA, Professor Livio Garattini Introduction: Health care in Italy is… Read More »

Efficient production of recombinant parathyroid hormone (rPTH) fragment 1-34 in the methylotrophic yeast Hansenula polymorpha

Published in: Volume 2 / Year 2013 / Issue 3
Author(s): ,
Page: 114-22

Author byline as per print journal: Frank Mueller, MSc, Manal Moussa, MSc, Maria El Ghazaly, MSc, Jan Rohde, PhD, Nicole Bartsch, MSc, Antje Parthier, PhD, Frank Kensy, Dr Ing Background:… Read More »

How do regional sickness funds encourage more rational use of medicines, including the increase of generic uptake? A case study from Austria

Published in: Volume 2 / Year 2013 / Issue 2
Author(s): ,
Page: 65-75

Objective: To analyse similarities and differences between activities carried out by Austrian sickness funds to encourage more rational use of medicines, including increasing generics uptake. Methods: Semi-structured interviews with pharmacoeconomic… Read More »

The generic pharmaceutical industry: moving beyond incremental innovation towards re-innovation

Published in: Volume 2 / Year 2013 / Issue 1
Author(s): , ,
Page: 13-9

Background: Due to the declining innovativeness of the classic R & D model in the original pharmaceutical industry, the generic pharmaceutical industry is aiming to become an innovation generator itself.… Read More »

Saving money in the European healthcare systems with biosimilars

Published in: Volume 1 / Year 2012 / Issue 3-4
Author(s): , , ,
Page: 120-6

Introduction: The use of biotechnological manufactured drugs, or biologicals, has increased massively over the past few years. Used especially in the treatment of cancer and other severe diseases, biologicals incur high… Read More »

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Published in: Volume 8 / Year 2019 / Issue 2
Author(s): ,

Author byline as per print journal: Brian Godman1,2,3,4, BSc, PhD; Andrew Hill5; Professor Steven Simoens6, MSc, PhD; Amanj Kurdi1,7, BSc, PhD; Jolanta Gulbinovič8, MD, PhD; Antony P Martin2,9; Angela Timoney1,10; Dzintars… Read More »

Pharmacy Chain Drives Choice among Manufacturers of Generic Drugs in the US Medicare Population

Author(s): , ,

Abstract: Background: Drug pricing and availability are key concerns for reducing health care costs and meeting patient needs. There is a complex chain of manufacturers, payers, wholesalers, retailers, patients, and… Read More »

Page 4 of 4 « Previous1 2 3 4
Go Back Print